FGEN Working Capital Per Revenue	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Working Capital Change	-7.73 %	-44.51 %	-65.09 %	-71.99 %	-53.68 %
Y / Y Revenue Change	-95.1 %	-	15.45 %	14.26 %	54.59 %
Working Capital Per Revenue	0.63	0.42	0.43	0.59	0.85
Working Capital Per Revenue Ranking	#	#	#	#	#
Seq. Working Capital Change	18.89 %	17.04 %	-11.29 %	-25.25 %	-28.5 %
Seq. Revenue Change	-	-	-8.51 %	-9.41 %	105.99 %

New: More FGEN's historic Working Capital Per Revenue Ratios >>

See FGEN Capital expenditures by quarter >> Back to FGEN Financial Strength Comparisons >> See FGEN Balance Sheets

Comment on FGEN's Working Capital Per Revenue in the first quarter 2025

Fibrogen Inc 's Working Capital Per Revenue sequentially grew to 0.63 during the Q1 2025, above the company average. Due to increase of revenue in the Q1 2025 year on year by -95.1%.

Within Healthcare sector Fibrogen Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q1 2025 relative to the prior quarter at no. .

Working Capital Per Revenue Ranking
Within:	No.
Industry	#
Sector	#
S&P 500	#

Working Capital Per Revenue Statistics
High	Average	Low
0	0	0

Financial Statements
Fibrogen Inc 's Working Capital	$ 75 Millions	Visit FGEN's Balance sheet
Fibrogen Inc 's Revenues	$ 3 Millions	Visit FGEN's Income Statement
Where are FGEN's Sales coming from?		Visit FGEN's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2025, within Healthcare Sector	Working Capital Per Revenue
Arcturus Therapeutics Holdings Inc	1.72
Meiragtx Holdings Plc	1.69
Theravance Biopharma inc	1.67
Schrodinger Inc	1.67
Vanda Pharmaceuticals Inc	1.65
Cytek Biosciences Inc	1.65
Personalis Inc	1.64
Sight Sciences Inc	1.60
Zai Lab Limited	1.59
Cryoport inc	1.57
Cue Biopharma Inc	1.56
Ligand Pharmaceuticals Incorporated	1.55
Siga Technologies Inc	1.51
Sintx Technologies Inc	1.49
Spero Therapeutics Inc	1.47
Monte Rosa Therapeutics Inc	1.47
Repligen Corp	1.47
Aquestive Therapeutics Inc	1.44
Aurinia Pharmaceuticals Inc	1.40
Procept Biorobotics Corporation	1.40
Lipocine Inc	1.38
Tarsus Pharmaceuticals Inc	1.36
Regenxbio Inc	1.34
Pulmonx Corporation	1.33
Arcutis Biotherapeutics Inc	1.32
Sensus Healthcare Inc	1.30
Century Therapeutics inc	1.28
Stoke Therapeutics Inc	1.28
The Beauty Health Company	1.28
Wave Life Sciences Ltd	1.27

Date modified: 2025-05-15T04:07:47+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com